vector. The company’s lead gene therapy, BV-702, is AAV-based and is in preclinical development for Alzheimer’s disease. It improved cognition and calculated biological age (telomere length ...
Hosted on MSN2mon
Scientists grow human brains in space to treat Alzheimer'sNearly 600,000 Americans are diagnosed with either Alzheimer's or Parkinson's each ... to truly test the effectiveness of the new viral vector treatment. 'Doing research in space is not something ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback